Meghna is an NIHR Clinician Scientist/ Advanced Fellow at the Centre for Epidemiology Versus Arthritis, University of Manchester and Consultant Rheumatologist at Salford Royal Hospital. She is an epidemiologist leading a programme of work on using digital data to assess opioid safety and utilisation to improve personalisation of care. Her research interests include addressing clinically important questions through pharmacoepidemiology, by utilising digital data via EHRs from both primary/ secondary care and other digital sources. Prior to her NIHR fellowship she was awarded a Presidential Fellowship for 2 years and held an NIHR Academic Clinical Lectureship. Her PhD, funded by an MRC Clinical Pharmacology & Therapeutics fellowship, evaluated the effectiveness and safety of biologic drugs in rheumatic diseases using national observational datasets and registry data. She is the 2018 UK recipient of the Farr Institute (HDR UK)/ Institute for Clinical and Evaluative Sciences Canadian Fellowship and the 2019 recipient of the British Society for Rheumatology Young Investigator Award. 

She has served on the NICE External assessment group for the evaluation of TNFi therapeutic drug monitoring Diagnostic Assessment Committee & the MHRA Opioids Expert Advisory Group. She has been part of the European/ EULAR task forces for management of rheumatoid arthritis, Therapeutic drug monitoring of biologics and Remote Monitoring of Rheumatic and Musculoskeletal Conditions

Pharmacoepidemiology (biologics, opioids), digital epidemiology, personalised medicine, biomarkers of treament response, therapeutic drug monitoring, research implementation into practice

Self-funded PhD projects:

Use of digital data to evaluate the benefits and harms associated with opioids for non-cancer pain

https://www.findaphd.com/phds/project/use-of-digital-data-to-evaluate-the-benefits-and-harms-associated-with-opioids-for-non-cancer-pain/?p135028